SyntekaBio, Inc. (KOSDAQ:226330)

SyntekaBio Statistics

Total Valuation

SyntekaBio has a market cap or net worth of KRW 82.60 billion. The enterprise value is 73.38 billion.

Market Cap	82.60B
Enterprise Value	73.38B

Important Dates

The last earnings date was Friday, April 3, 2026.

Earnings Date	Apr 3, 2026
Ex-Dividend Date	n/a

Share Statistics

SyntekaBio has 24.26 million shares outstanding. The number of shares has increased by 2.20% in one year.

Current Share Class	24.26M
Shares Outstanding	24.26M
Shares Change (YoY)	+2.20%
Shares Change (QoQ)	+8.58%
Owned by Insiders (%)	15.32%
Owned by Institutions (%)	n/a
Float	20.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.09
PB Ratio	2.60
P/TBV Ratio	2.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.22
EV / Sales	21.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.88

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.22.

Current Ratio	1.42
Quick Ratio	1.41
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.67
Interest Coverage	-3.79

Financial Efficiency

Return on equity (ROE) is -61.27% and return on invested capital (ROIC) is -18.91%.

Return on Equity (ROE)	-61.27%
Return on Assets (ROA)	-14.91%
Return on Invested Capital (ROIC)	-18.91%
Return on Capital Employed (ROCE)	-31.39%
Weighted Average Cost of Capital (WACC)	9.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.72% in the last 52 weeks. The beta is 0.63, so SyntekaBio's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-57.72%
50-Day Moving Average	3,369.10
200-Day Moving Average	4,606.33
Relative Strength Index (RSI)	55.25
Average Volume (20 Days)	160,730

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SyntekaBio had revenue of KRW 3.43 billion and -17.38 billion in losses. Loss per share was -1,115.00.

Revenue	3.43B
Gross Profit	3.42B
Operating Income	-10.76B
Pretax Income	-17.38B
Net Income	-17.38B
EBITDA	-8.74B
EBIT	-10.76B
Loss Per Share	-1,115.00

Balance Sheet

The company has 16.35 billion in cash and 7.13 billion in debt, with a net cash position of 9.22 billion or 380.04 per share.

Cash & Cash Equivalents	16.35B
Total Debt	7.13B
Net Cash	9.22B
Net Cash Per Share	380.04
Equity (Book Value)	31.78B
Book Value Per Share	1,918.18
Working Capital	5.19B

Cash Flow

In the last 12 months, operating cash flow was -10.65 billion and capital expenditures -11.01 million, giving a free cash flow of -10.66 billion.

Operating Cash Flow	-10.65B
Capital Expenditures	-11.01M
Depreciation & Amortization	2.02B
Net Borrowing	-8.85B
Free Cash Flow	-10.66B
FCF Per Share	-439.47

Margins

Gross Margin	99.87%
Operating Margin	-313.91%
Pretax Margin	-506.76%
Profit Margin	n/a
EBITDA Margin	-254.90%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SyntekaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.20%
Shareholder Yield	-2.20%
Earnings Yield	-21.04%
FCF Yield	-12.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SyntekaBio has an Altman Z-Score of 0.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.46
Piotroski F-Score	4